Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01520649
What this trial is testing

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

Who this might be right for
Depression
Neuralstem Inc. 26
Early research (Phase 1)Study completedNCT01685359
What this trial is testing

PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant

Who this might be right for
Healthy
Azidus Brasil 80
Post-approval studies (Phase 4)Study completedNCT01260142
What this trial is testing

A PK/PD Study of Fospropofol Disodium Compared With Propofol Injectable Emulsion

Who this might be right for
Anesthesia
Eisai Inc. 36
Early research (Phase 1)Study completedNCT04291079
What this trial is testing

SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)

Who this might be right for
Cancer
Scholar Rock, Inc. 112
Not applicableUnknownNCT01582360
What this trial is testing

2012_PharmacoCRRT-study:Pharmacokinetics of Anti-infectives in Critically Ill Patients in Need of Continuous Renal Replacement Therapy (CRRT)

Who this might be right for
Critically IllAcute Renal FailureAcute Kidney Injury
Oslo University Hospital 640
Early research (Phase 1)Study completedNCT04277910
What this trial is testing

A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004

Who this might be right for
Healthy
Xi'an Biocare Pharma Ltd. 88
Early research (Phase 1)Study completedNCT01585649
What this trial is testing

PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma

Who this might be right for
Ewing Family of Tumors, Rhabdomyosarcoma
Merckle GmbH 21
Early research (Phase 1)Study completedNCT03586908
What this trial is testing

PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects

Who this might be right for
Healthy Volunteer
pH Pharma 24
Not applicableLooking for participantsNCT07243483
What this trial is testing

Study of the Relationship Between the Pharmacokinetics (PK) and Pharmacodynamics of Venetoclax in Patients With Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloid Leukemia
Centre Leon Berard 100
Early research (Phase 1)Active Not RecruitingNCT05501717
What this trial is testing

Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT03131479
What this trial is testing

Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 53
Large-scale testing (Phase 3)Study completedNCT02563327
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis

Who this might be right for
Tuberculosis
Centers for Disease Control and Prevention 2,516
Early research (Phase 1)Study completedNCT06698861
What this trial is testing

A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers

Who this might be right for
PK in Healthy Volunteers
PharmaEssentia 30
Testing effectiveness (Phase 2)WithdrawnNCT03767270
What this trial is testing

Safety, Tolerability and PK/PD Evaluation of Intravenous Administration of MRT5201 in Patients With OTC Deficiency

Who this might be right for
Ornithine Transcarbamylase Deficiency
Translate Bio, Inc.
Testing effectiveness (Phase 2)Study completedNCT01718041
What this trial is testing

Versartis Trial in Children to Assess Long-Acting Growth Hormone

Who this might be right for
Pediatric Growth Hormone Deficiency
Versartis Inc. 64
Early research (Phase 1)Study completedNCT03694041
What this trial is testing

Safety, Tolerability, PK and PD of SAD or MAD of APX-115 in Healthy Male Volunteers

Who this might be right for
HealthySafety
Aptabio Therapeutics, Inc. 88
Early research (Phase 1)Study completedNCT04686279
What this trial is testing

Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM)

Who this might be right for
HIV/AIDSHIV Prevention
University of Pennsylvania 8
Testing effectiveness (Phase 2)Study completedNCT01189396
What this trial is testing

Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006

Who this might be right for
AsthmaBronchospasmChronic Obstructive Pulmonary Disease (COPD)
Amphastar Pharmaceuticals, Inc. 27
Post-approval studies (Phase 4)Study completedNCT02417246
What this trial is testing

Open-Labeled PK-PD Studies of Metoprolol ER

Who this might be right for
Blood Pressure
University of Florida 61
Early research (Phase 1)Study completedNCT01266954
What this trial is testing

An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer

Who this might be right for
Solid Tumours
GlaxoSmithKline 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation